Cargando…
SUMOylation Regulates Transcription by the Progesterone Receptor A Isoform in a Target Gene Selective Manner
Luminal breast cancers express estrogen (ER) and progesterone (PR) receptors, and respond to endocrine therapies. However, some ER+PR+ tumors display intrinsic or acquired resistance, possibly related to PR. Two PR isoforms, PR-A and PR-B, regulate distinct gene subsets that may differentially influ...
Autores principales: | Abdel-Hafiz, Hany A., Dudevoir, Michelle L., Perez, Daniel, Abdel-Hafiz, Mohamed, Horwitz, Kathryn B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871951/ https://www.ncbi.nlm.nih.gov/pubmed/29301281 http://dx.doi.org/10.3390/diseases6010005 |
Ejemplares similares
-
Control of progesterone receptor transcriptional synergy by SUMOylation and deSUMOylation
por: Abdel-Hafiz, Hany A, et al.
Publicado: (2012) -
SUMOylation modulates the transcriptional activity of androgen receptor in a target gene and pathway selective manner
por: Sutinen, Päivi, et al.
Publicado: (2014) -
Characterization of Nuclear Progesterone Receptor Isoforms in the Term Equine Placenta
por: Nagy, Ahmed M., et al.
Publicado: (2021) -
Intraovarian, Isoform-Specific Transcriptional Roles of Progesterone Receptor in Ovulation
por: Smith, Kirsten M., et al.
Publicado: (2022) -
Isoform specificity of progesterone receptor antibodies
por: Fabris, Victoria, et al.
Publicado: (2017)